Investigation and analysis of migraine diagnosis and treatment in general practitioners

doi:10.3969/j.issn.1006-7795.2023.03.019

Abstract

Abstract: Objective To evaluate the cognition and diagnosis of migraine of general practitioners, so as to provide reference for further improving the general practitioner’s ability to diagnose and treat migraine. Methods The questionnaire entitled “General Practitioners Migraine Diagnosis and Treatment Status Survey” was designed according to the relevant problems in the diagnosis and treatment of migraine. The demographic characteristics of the respondents and their mastery of the current clinical diagnosis and treatment of migraine were collected. From June 1 to September 30, 2021, 500 general practitioners were selected by the method of cross-sectional survey. A total of 500 questionnaires were sent and 450 (90%) valid questionnaires were collected. The results of 450 questionnaires were summarized and analyzed. Results The survey showed that the average age of 450 respondents was （36.6±7.2） years old, including 208 (46.22%) male general practitioners. 75.81% of the respondents had a bachelor's degree, and 39.72% of them owned intermediate professional titles (32.31% with senior professional titles and the remaining 28.97% with junior professional titles). In clinical practice, 85.58% of general practitioners had treated headache patients. Only 20.66% had studied the International Classification of Headache Disorders, 3rd edition (ICHD-3), and the knowledge of ICHD-3 among respondents from tertiary hospitals was significantly better than that those from primary and secondary hospitals (P<0.000 1). Only about 30% of the subjects correctly answered the duration and diagnostic criteria of migraine attacks. 56.74% of the respondents had considered the use of drugs for migraine prevention, but the knowledge of medication indications and drug choices still were needed. Conclusions There is still a gap in the current knowledge of migraine diagnosis and treatment among general practitioners. In the future, we should further strengthen the general practitioner in professional knowledge training to improve the general practitioner's ability of cognition and diagnosis and treatment on migraine, so as to reduce the disease burden of migraine.

Key words: migraine, diagnosis and treatment, questionnaire, demographic data

CLC Number:

R741

Zhao Huiqing, Zhang Yaqing. Investigation and analysis of migraine diagnosis and treatment in general practitioners[J]. Journal of Capital Medical University, 2023, 44(3): 482-486.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2023.03.019

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2023/V44/I3/482

References

［1］于生元. 全科医生在偏头痛诊疗中需要注意的几个问题［J］. 中华全科医师杂志, 2007, 6(2): 69－71.
［2］Steiner T J, Stovner L J, Jensen R, et al. Migraine remains second among the worlds causes of disability, and first among young women: findings from GBD2019［J］. J Headache Pain, 2020, 21(1): 137.
［3］GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990－2019: a systematic analysis for the Global Burden of Disease Study 2019［J］. Lancet, 2020, 396(10258): 1204－1222.
［4］Ashina M, Katsarava Z, Do T P, et al. Migraine: epidemiology and systems of care［J］. Lancet, 2021, 397(10283): 1485－1495.
［5］GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990－2016: a systematic analysis for the Global Burden of Disease Study 2016［J］. Lancet Neurol, 2018, 17(11): 954－976.
［6］陆佳洁, 赵红如. 偏头痛疾病负担研究进展［J］. 中国现代神经疾病杂志, 2022, 22(2): 69－72.
［7］Aljunaid M A, Jamal H H, Mubarak A A, et al. Levels and determinants of knowledge about chronic migraine diagnosis and management among primary health-care physicians in ministry of health, Jeddah 2019［J］. J Family Med Prim Care, 2020, 9(5): 2324－2331.
［8］Choudry H, Ata F, Naveed Alam M N, et al. Migraine in physicians and final year medical students: a cross-sectional insight into prevalence, self-awareness, and knowledge from Pakistan［J］. World J Methodol, 2022, 12(5): 414－427.
［9］Steiner T J, Birbeck G L, Jensen R H, et al. Headache disorders are third cause of disability worldwide［J］. J Headache Pain, 2015, 16(1): 58.
［10］Kernick D, Stapley S, Hamilton W. GPs classification of headache: is primary headache underdiagnosed?［J］. Br J Gen Pract, 2008, 58(547): 102－104.
［11］Dabilgou A A, Dravé A, Kyelem J M A, et al. Knowledge, attitudes, and management of general practitioners of the hospital districts of Ouagadougou about migraine (Burkina Faso)［J］. Pain Res Manag, 2021, 2021: 9327363.
［12］Guerrero A L, Negro A, Ryvlin P, et al. Need of guidance in disabling and chronic migraine identification in the primary care setting, results from the European MyLife anamnesis survey［J］. BMC Fam Pract, 2021, 22(1): 54.
［13］Kristoffersen E S, Faiz K W, Hansen J M, et al. The management and clinical knowledge of headache disorders among general practitioners in Norway: a questionnaire survey［J］. J Headache Pain, 2021, 22(1): 136.
［14］中华医学会疼痛学分会面痛学组.中国偏头痛防治指南［J］.中国疼痛医学杂志，2016，22（10）：721-727.
［15］Burch R C, Buse D C, Lipton R B. Migraine: epidemiology, burden, and comorbidity［J］. Neurol Clin, 2019, 37(4): 631－649.
［16］Lipton R B, Stewart W F, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study Ⅱ［J］. Headache, 2001, 41(7): 646－657.
［17］Yao C Y, Wang Y, Wang L J, et al. Burden of headache disorders in China, 1990－2017: findings from the Global Burden of Disease Study 2017［J］. J Headache Pain, 2019, 20(1): 102.
［18］Yu S Y, Liu R Z, Gang Z, et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey［J］. Headache, 2012, 52(4): 582－591.
［19］Gooch C L, Pracht E, Borenstein A R. The burden of neurological disease in the United States: a summary report and call to action［J］. Ann Neurol, 2017, 81(4): 479－484.
［20］Frese T, Druckrey H, Sandholzer H. Headache in general practice: frequency, management, and results of encounter［J］. Int Sch Res Notices, 2014, 2014: 169428.
［21］Thiele A, Strau S, Angermaier A, et al. Treatment realities of headache disorders in rural Germany by the example of the region of western Pomerania［J］. Brain Sci, 2021, 11(7): 839.

[1]	Du Tianshu, Gong Xiaoli, Aizier Ainiwaer, Zhang Zhen, Liu Yang, Wang Xiaomin, Zhang Ting. CD200R1 deletion promotes LPS-induced endocytosis of microglia [J]. Journal of Capital Medical University, 2022, 43(1): 82-90.
[2]	Wang Mengyue, Zhao Xin, Cao Xiao, Wang Ke, Jia Jun. Motion initiation analysis of voluntary movements in Parkinsonian mice [J]. Journal of Capital Medical University, 2021, 42(4): 553-558.
[3]	Liu Xiran, Xu Yan, Wang Weizhi, Wang Lihua, Zhang Meini, Li Chunyang, Dong Huiqing, Li Guozhong, Liu Hongbo, Fu Jin, Jin Tao, Guan Yangtai, Tan Guojun, Guo Li, Zhang Xinghu. Clinical features and difficulties in diagnosis of multiple sclerosis in China [J]. Journal of Capital Medical University, 2021, 42(3): 360-366.
[4]	Hou Yutong, Yang Shuna, Li Yue, Li Xuanting, Hu Wenli. White matter hyperintensities are related to functional disturbance of upper and lower extremities [J]. Journal of Capital Medical University, 2021, 42(3): 385-390.
[5]	Yuan Huili, Gong Xiaoli, Fan Zheng, Liang Zhigang, Wang Xiaomin. Effects and mechanism of Tenuigenin on lipopolysaccharide induced Parkinson's disease model [J]. Journal of Capital Medical University, 2020, 41(6): 914-922.
[6]	Li Yan. A leader in clinical research on dementia in China who guards the “soul of memory”——Professor Jia Jianping [J]. Journal of Capital Medical University, 2020, 41(5): 822-827.
[7]	Gong Xiaoli, Liu Mengru, Wang Le, Liu Yang, Zhang Ting, Sun Ying, Wang Xiaomin. Role of α-synuclein in microglia inflammation and phagocytosis [J]. Journal of Capital Medical University, 2018, 39(5): 693-698.
[8]	Liu Mengru, Gong Xiaoli, Wang Le, Liu Yang, Zhang Ting, Wang Xiaomin. Effect of lipopolysaccharide on the expression of α-synuclein in the intestinal tract [J]. Journal of Capital Medical University, 2018, 39(4): 557-562.
[9]	Hao Yuanyuan, Sun Wanling. Monoclonal protein and peripheral neuropathy [J]. Journal of Capital Medical University, 2018, 39(3): 344-348.
[10]	Ma Jun, Wang Zhaohui, Gu Xuesong, Man Fengyuan. Study of ApoEε4 gene combined with sMRI in mild cognitive impairment [J]. Journal of Capital Medical University, 2017, 38(1): 59-62.
[11]	Wang Xue, Shen Jiamei, Gao Ge, Duan Chunli, Lu Lingling, Yang Hui. Study of PINK1 rescuing the mitochondrial dysfunction induced by α-synuclein [J]. Journal of Capital Medical University, 2016, 37(1): 70-75.
[12]	Zhang Ruyi, Zhang Li, Li Lin. Mitochondrial dysfunction, α-synuclein and Parkinson's disease [J]. Journal of Capital Medical University, 2015, 36(6): 861-864.
[13]	Lu Lingling, Shi Yuqing, Wei Yufei, Jia Huanzhen, Qiao Fangwei, Yang Hui. Regulatory effects of α-synuclein and PINK1 on Nurr1 activity [J]. Journal of Capital Medical University, 2015, 36(6): 895-901.
[14]	Li Hui, Qi Zhigang, Li Kuncheng. Review of mechanisms of acupuncture in treatment of Alzheimer's disease [J]. Journal of Capital Medical University, 2015, 36(5): 809-813.
[15]	Wang Zhiqun, Li Kuncheng. Resting state functional MRI, DTI and PWI in the Alzheimer's disease [J]. Journal of Capital Medical University, 2015, 36(4): 640-644.